Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S Kochel
PCSK9 Inhibitors - Alirocumab and Evolucumab: Key Insights on Differentiation in a Generic Market
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
PCSK9 Peptide Inhibitors
Science-Business eXchange
PCSK9 Inhibitors: A Technology Worth Paying For?
PharmacoEconomics
Health Policy
Public Health
Occupational Health
Pharmacology
Environmental
Are PCSK9 Inhibitors Cost Effective?
PharmacoEconomics
Health Policy
Public Health
Occupational Health
Pharmacology
Environmental
PCSK9 Inhibitors: When Statins Aren't Enough
Prescriber
Pharmacology
Focus on PCSK9 Inhibitors: From Genetics to Clinical Practice
Postgraduate Medicine
Medicine
Lipoprotein(a) Reductions From PCSK9 Inhibition and Major Adverse Cardiovascular Events: Pooled Analysis of Alirocumab Phase 3 Trials
Atherosclerosis
Cardiovascular Medicine
Cardiology
Key Recent Advances in Atherosclerosis Treatment With Modern Lipid-Lowering Drugs: The New Frontier With PCSK9 Inhibitors
European Cardiology Review
Cardiovascular Medicine
Cardiology
Consumer Choice Between Common Generic and Brand Medicines in a Country With a Small Generic Market
Journal of managed care & specialty pharmacy
Health Policy
Pharmacy
Pharmaceutical Science
A Review of Health Technology Assessments (HTA) of PCSK9 Inhibitors (PSCK9I)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental